Kissei Pharmaceutical saw the highest growth of 4.99% in patent filings and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 4.99% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Kissei Pharmaceutical’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Kissei Pharmaceutical has been focused on protecting inventions in Australia(AU) with two publications in Q2 2024
The Australia(AU) Patent Office dominates the patent filings with nearly 40% of filings. The Australia(AU), Japan(JP), Mexico(MX), and European Patent Office(EPO) patent Office are among the top ten patent offices where Kissei Pharmaceutical is filings its patents. Among the top granted patent authorities, Kissei Pharmaceutical has 50% of its grants in European Patent Office(EPO) and 50% in United States(US).
Roche could be the strongest competitor for Kissei Pharmaceutical
Patents related to addiction and rare diseases lead Kissei Pharmaceutical's portfolio
Kissei Pharmaceutical has the highest number of patents in addiction followed by, rare diseases. For addiction, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Endometriosis related patents lead Kissei Pharmaceutical portfolio followed by pain, and uterine leiomyoma (uterine fibroids)
Kissei Pharmaceutical has highest number of patents in endometriosis followed by pain, uterine leiomyoma (uterine fibroids), dual energy x-ray absorptiometry (dexa), and sleep disorders. For endometriosis, nearly 17% of patents were filed and 20% of patents were granted in Q2 2024.
For comprehensive analysis of Kissei Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
